会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Anthracycline derivatives, their preparation and use
    • 蒽环类衍生物,其制备和用途
    • US4327029A
    • 1982-04-27
    • US2072
    • 1979-01-08
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • A61K31/65A61K31/70A61K31/7028A61K31/7034A61K31/704A61P35/00C07H15/252C07C39/40
    • C07H15/252Y10S514/908
    • Compounds of the formula: ##STR1## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl or benzyl; A and B are OH or A and B are OCOOR.sub.4 or B is OH and A is OCOOR.sub.4 ; and R.sub.4 is alkyl which are intermediates for the preparation of antitumor compounds of the formula: ##STR2## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl; a C.sub.3 -C.sub.6 cycloalkyl substituted by a halogen, hydroxy, methoxy, amino or dimethylamino group; phenyl or phenyl substituted with nitro, chlorine or methoxy thiazyl, pyridyl, pyrazyl; or a phenyl-alkyl group of the formula X--Phe--(CH.sub.2).sub.n --, in which X is hydrogen, halogen, hydroxyl, amino, or nitro and n is an integer from 1 to 2; R.sub.2 is hydrogen, hydroxyl or acyloxy (R--COO--); where R is an alkyl having from 1 to 11 carbon atoms; and R.sub.3 is hydrogen or trifluoroacetyl and salts thereof with pharmaceutically acceptable acids.
    • 下式的化合物:其中R 1是C 2 -C 4烷基; C3-C6环烷基或苄基; A和B是OH或A,B是OCOOR4或B是OH,A是OCOOR4; 和R4是作为制备下式的抗肿瘤化合物的中间体的烷基:其中R 1是C 2 -C 4烷基; C3-C6环烷基; 被卤素,羟基,甲氧基,氨基或二甲氨基取代的C3-C6环烷基; 苯基或被硝基,氯或甲氧基噻唑取代的苯基,吡啶基,吡嗪基; 或式X-Phe-(CH2)n-的苯基 - 烷基,其中X是氢,卤素,羟基,氨基或硝基,n是1至2的整数; R2是氢,羟基或酰氧基(R-COO-); 其中R是具有1至11个碳原子的烷基; 并且R 3是氢或三氟乙酰基及其盐与药学上可接受的酸。
    • 6. 发明授权
    • Anthracycline derivatives, their preparation and use
    • 蒽环类衍生物,其制备和用途
    • US4166848A
    • 1979-09-04
    • US850933
    • 1977-11-14
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • Luigi BernardiPaolo MasiAntonino SuaratoFederico Arcamone
    • A61K31/65A61K31/70A61K31/7028A61K31/7034A61K31/704A61P35/00C07H15/252C07G3/00C07G11/00
    • C07H15/252Y10S514/908
    • Disclosed are antitumor compounds of the formula: ##STR1## wherein R.sub.1 is a C.sub.2 -C.sub.4 alkyl; a C.sub.3 -C.sub.6 cycloalkyl; a C.sub.3 -C.sub.6 cycloalkyl substituted by a halogen, hydroxy, methoxy, amino or dimethylamino group; phenyl or phenyl substituted with nitro, chlorine or methoxy; thiazyl, pyridyl, pyrazyl; or a phenyl-alkyl group of the formula X--Phe--(CH.sub.2).sub.n --, in which X is hydrogen, halogen, hydroxyl, amino, or nitro and n is an integer from 1 to 2; R.sub.2 is hydrogen, hydroxyl or acyloxy (R--COO--), where R is an alkyl having from 1 to 11 carbon atoms; and R.sub.3 is hydrogen or trifluoroacetyl and salts thereof with pharmaceutically acceptable acids. Compounds I are prepared by condensing the aglycones thereof with 2,3,6-trideoxy-3-trifluoroacetamido-4-O-trifluoro-acetyl-.alpha.-L-lyxopyranosyl chloride according to a conventional technique.
    • 公开了下式的抗肿瘤化合物:其中R 1是C 2 -C 4烷基; C3-C6环烷基; 被卤素,羟基,甲氧基,氨基或二甲氨基取代的C3-C6环烷基; 苯基或被硝基,氯或甲氧基取代的苯基; 噻嗪基,吡啶基,吡嗪基; 或式X-Phe-(CH2)n-的苯基 - 烷基,其中X是氢,卤素,羟基,氨基或硝基,n是1至2的整数; R2是氢,羟基或酰氧基(R-COO-),其中R是具有1至11个碳原子的烷基; 并且R 3是氢或三氟乙酰基及其盐与药学上可接受的酸。 通过根据常规技术将其糖苷配基与2,3,6-三脱氧-3-三氟乙酰氨基-4-O-三氟乙酰基-β-L-吡喃葡糖酰氯缩合制备化合物I.
    • 10. 发明授权
    • Methods for preparing cephalosporins
    • 头孢菌素的制备方法
    • US4035362A
    • 1977-07-12
    • US672527
    • 1976-03-31
    • Paolo MasiMaurizio FoglioGiovanni FranceschiAntonino SuaratoGianfranco CainelliFederico Arcamone
    • Paolo MasiMaurizio FoglioGiovanni FranceschiAntonino SuaratoGianfranco CainelliFederico Arcamone
    • C07D205/08C07D205/095C07D501/08C07D501/10C07D501/20
    • C07D501/08C07D205/095
    • A process for preparing cephalosporins of the structure: ##STR1## where R is any of hydrogen, C.sub.1 to C.sub.4 alkyl, t-butoxy, benzyloxy, cyano-methyl, thienyl-methyl, furyl-methyl, naphthyl-methyl, phenyl-methyl, phenoxy-methyl, phenoxy-isopropyl, pyridyl-4-thiomethyl and tetrazolyl-1-methyl;R.sub.1 is any of hydroxyl, C.sub.1 to C.sub.4 alkoxy, benzyloxy, p-methoxy- (or nitro-) benzyloxy, benzhydryloxy, triphenylmethoxy, phenacyloxy, p-halophenacyloxy and trichloroethoxy;Z is any of hydrogen, hydroxyl, --O--CO--C.sub.1 -C.sub.4 alkyl, --O--C.sub.1 -C.sub.4 alkyl, --Br, --I, --Cl, --N.sub.3, --NH.sub.2, --O--CO--CH.sub.3, --O--CO--NH.sub.2 and an -S-mononuclear nitrogen heterocyclic ring,By reacting compounds of the structure: ##STR2## IN WHICH R, R.sub.1, and Z are as above defined; R.sub.2 and R.sub.3 are the same or different and represent a C.sub.1 to C.sub.4 alkyl, a mononuclear aryl ring, --CN, a mononuclear heterocyclic ring or the radicals --COR.sub.4, COOR.sub.4, --PO(OR.sub.4).sub.2, --CO--NHR.sub.4 or R.sub.2 and R.sub.3 together may represent: ##STR3## where T represents >CH.sub.2, -N--R.sub.4 ; and R.sub.4 is lower alkyl, a mononuclear aryl ring or a mononuclear heterocyclic ring,Alone or as mixtures with each other in a suitable solvent at a temperature between -100 and +120.degree. C with a strong base to give compounds of formula I that are a mixture of .DELTA..sub.2 and .DELTA..sub.3 cephem-derivatives from which the .DELTA..sub.3 cephem derivatives can be obtained.
    • 一种制备结构式头孢菌素的方法:其中R是氢,C1-C4烷基,叔丁氧基,苄氧基,氰基 - 甲基,噻吩基 - 甲基,呋喃基 - 甲基,萘基 - 甲基,苯基 - 甲基 ,苯氧基甲基,苯氧基 - 异丙基,吡啶基-4-硫代甲基和四唑基-1-甲基; R1是羟基,C1〜C4烷氧基,苄氧基,对甲氧基 - (或硝基)苄氧基,二苯甲氧基,三苯基甲氧基,苯甲酰氧基,对卤代苯氧基和三氯乙氧基中的任一个。 Z是氢,羟基,-O-CO-C 1 -C 4烷基,-O-C 1 -C 4烷基,-Br,-I,-Cl,-N 3,-NH 2,-O-CO-CH 3,-O -CO-NH 2和-S-单核氮杂环,通过反应结构的化合物:其中R,R 1和Z如上所定义;其中R,R 1和Z如上所定义; R2和R3相同或不同,表示C1至C4烷基,单核芳基环,-CN,单核杂环或基团-COR4,COOR4,-PO(OR4)2,-CO-NHR4或R2和 R3一起可以表示:其中T表示> CH 2,-N-R 4; 并且R 4为低级烷基,单核芳基环或单核杂环,单独或混合于适宜溶剂中的温度为-100℃和+120℃之间的强碱,得到式I化合物 可以获得DELTA 2和DELTA 3头孢烯衍生物的混合物,其中可以获得DELTA 3头孢烯衍生物。